Opticare Health (AMEX:OPT)
Historical Stock Chart
From Dec 2019 to Dec 2024
OptiCare Reports Fourth Quarter and Year End 2004 Financial
Results
WATERBURY, Conn., March 31 /PRNewswire-FirstCall/ -- OptiCare Health Systems,
Inc. (AMEX:OPT) announced today for the fourth quarter ended December 31, 2004,
total net revenue on a continuing operations basis increased approximately 3.9%
to $14,378,000 from $13,842,000 in the same period in 2003. For the full year,
total net revenue on a continuing operations basis decreased approximately 3.6%
to $58,903,000 from approximately $61,099,000 in 2003. Results from continuing
operations exclude the Company's Distribution Segment which was sold on January
12, 2005.
OptiCare also reported income from continuing operations for the fourth quarter
ended December 31, 2004 of $286,000 compared to a loss of $640,000 for the
fourth quarter 2003. For the year ended December 31, 2004, OptiCare reported
income from continuing operations of $38,000 compared to a loss from continuing
operations of $7,053,000 for the year ended December 31, 2003. The loss in
2003 resulted primarily from a one-time charge of $1,896,000 related to an
early extinguishment of debt and the write-off of $4,927,000 in deferred tax
assets.
"Our 2004 operating results demonstrate that the Company continues to focus on
its core businesses of Consumer Vision and Managed Vision and has established a
solid foundation to build upon," stated, Christopher J. Walls, OptiCare's
President and Chief Executive Officer.
In addition, on January 12, 2005, OptiCare closed a series of transactions
which resulted in a significant debt reduction while increasing its equity.
Taken together, these transactions lowered OptiCare's long-term debt and
accounts payable by approximately $6,145,000 and $1,530,000, respectively, and
increased its equity by approximately $4,445,000. The transactions included,
among other things, the following:
* Palisade Concentrated Equity Partnership, L.P., OptiCare's majority
stockholder, and Linda Yimoyines, the spouse of OptiCare's Chairman and
former Chief Executive Officer, purchased for approximately $4,445,000
of OptiCare's Series D Preferred Stock;
* OptiCare sold, effective December 31, 2004, substantially all of the
assets and certain liabilities of its Distribution Division, which
consisted of Wise Optical and its Optical Buying Group, for an
aggregate purchase price of approximately $4,150,000, less a working
capital adjustment of approximately $575,000 and closing costs of
approximately $349,000, to Wise Optical, LLC and AECC/Pearlman Buying
Group, LLC, both entities formed by OptiCare's Chairman and former
Chief Executive Officer; and
* OptiCare amended the terms of its revolving credit, term loan and
security agreement with OptiCare's senior lender, to reduce the
tangible net worth covenant for December 2004 and January 2005 from
($3,000,000) to ($6,500,000). Without this amendment, OptiCare would
have been in violation of the tangible net worth covenant at December
31, 2004. Under the revolving credit, term loan and security
agreement, as amended; OptiCare must maintain a tangible net worth of
at least ($3,000,000) million after February 1, 2005.
"The recent sale of our Distribution Segment and the issuance of the Series D
Preferred Stock significantly lowered our debt, increased stockholders' equity
and will reduce our debt service on a prospective basis which should improve
the Company's financial performance in 2005," stated Mr. Walls.
About OptiCare Health Systems, Inc.
OptiCare Health Systems, Inc. is an integrated eye care services company
focused on vision benefits management and consumer vision services, including
medical, surgical and optometric services and optical retail.
This press release contains forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of 1995,
including statements regarding OptiCare's 2005 operating or financial
performance. OptiCare's actual results could differ materially from those
expressed or indicated by any forward-looking statements. Factors that could
cause or contribute to such differences include, but are not limited to, the
risk that OptiCare may not retain and attract qualified employees, OptiCare may
not realize one or more of the expected benefits and efficiencies of the
transaction including its debt reduction or equity investment, the impact of
current and future governmental regulations, OptiCare's ability to successfully
and profitably manage its operations, and growth of the operations, if any, the
risks related to managed care contracting, and the ability of OptiCare to
successfully raise capital on commercially reasonable terms, if at all.
Investors are cautioned that all forward-looking statements involve risks and
uncertainties, including those risks and uncertainties detailed in OptiCare's
filings with the Securities and Exchange Commission, including its Annual
Report on Form 10-K for the fiscal year ending December 31, 2004.
Forward-looking statements speak only as of the date they are made, and
OptiCare undertakes no duty or obligation to update any forward-looking
statements in light of new information or future events.
OptiCare Health Systems, Inc. And Subsidiaries
Consolidated Balance Sheets
(Amounts In Thousands, Except Share And Per Share Data)
December 31,
2004 2003
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $2,228 $1,695
Accounts receivable, net 2,164 2,044
Inventories 1,851 1,773
Assets held for sale 7,894 11,578
Notes receivable 82 105
Other current assets 599 354
Total Current Assets 14,818 17,549
Property and equipment, net 2,628 2,761
Goodwill 16,663 16,565
Intangible assets, net 1,068 1,179
Assets held for sale, non-current 1,150 4,670
Deferred debt issuance costs, net 342 398
Notes receivable, less current portion 734 791
Restricted cash 1,413 1,158
Other assets 998 784
TOTAL ASSETS $ 39,814 $45,855
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable 2,727 734
Claims payable and claims incurred but not
reported 1,897 1,534
Accrued salaries and related expenses 2,743 2,186
Accrued expenses 1,874 1,184
Current portion of long-term debt 332 10,818
Current portion of capital lease obligations 11 10
Liabilities of held for sale business 5,683 6,755
Other current liabilities 1,119 407
Total Current Liabilities 16,386 23,628
NON-CURRENT LIABILITIES:
Long-term debt, less current portion 10,024 1,775
Capital lease obligations, less current portion 19 --
Other liabilities 1,476 405
Total Non-Current Liabilities 11,519 2,180
COMMITMENTS AND CONTINGENCIES (Notes 10, 12, and 19)
SERIES B 12.5% REDEEMABLE, CONVERTIBLE PREFERRED
STOCK AT AGGREGATE LIQUIDATION PREFERENCE-RELATED
PARTY 6,344 5,635
STOCKHOLDERS' EQUITY:
Series C Preferred Stock, $.001 par value
($16,251 aggregate liquidation preference);
406,158 shares issued and outstanding at
December 31, 2004 and December 31, 2003,
respectively 1 1
Common Stock, $0.001 par value; 150,000,000 shares
authorized; 30,638,283 and 30,386,061 shares issued
and outstanding at December 31, 2004 and 2003,
respectively 31 30
Additional paid-in-capital 79,192 79,700
Accumulated deficit (73,659) (65,319)
TOTAL STOCKHOLDERS' EQUITY 5,565 14,412
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $39,814 $45,855
OptiCare Health Systems, Inc. And Subsidiaries
Condensed Consolidated Statements Of Operations
(Amounts In Thousands, Except Share Data)
Three Months Twelve Months
Ended December 31, Ended December 31,
2004 2003 2004 2003
(Unaudited)
NET REVENUES:
Managed vision $ 6,631 $ 6,104 $25,495 $ 28,111
Product sales 2,649 2,745 11,580 11,295
Other services 4,635 4,989 19,907 18,971
Other income 463 4 1,921 2,722
Total net revenues 14,378 13,842 58,903 61,099
OPERATING EXPENSES:
Medical claims expense 4,882 4,749 19,156 22,000
Cost of product sales 927 1,056 4,128 3,837
Cost of services 1,948 2,080 8,322 8,001
Selling, general and
administrative 5,777 5,842 25,053 24,165
Loss from early
extinguishment of debt -- 48 -- 1,896
Depreciation 203 335 848 1,168
Amortization 31 27 117 114
Interest 304 330 1,190 2,044
Total operating
expenses 14,072 14,467 58,814 63,225
Income (loss) from
continuing operations
before tax 306 (625) 89 (2,126)
Income tax expense 20 15 51 4,927
Income (loss) from
continuing operations 286 (640) 38 (7,053)
Discontinued operations:
Loss from discontinued
operations, net of
income tax (1,131) (1,220) (3,973) (5,300)
Loss on disposal of
discontinued operations (3,401) -- (4,405) --
Loss from discontinued
operations (4,532) (1,220) (8,378) (5,300)
Net loss (4,246) (1,860) (8,340) (12,353)
Preferred stock
dividends (181) (159) (709) (618)
Net loss available to
common stockholders $ (4,427) $ (2,019) $(9,049) $ (12,971)
EARNINGS (LOSS) PER SHARE:
Income (loss) from
continuing operations:
Basic $0.00 $ (0.03) $ (0.02) $ (0.25)
Diluted $0.00 $ (0.03) $ (0.02) $ (0.25)
Loss from discontinued
operations:
Basic $ (0.15) $ (0.04) $ (0.28) $ (0.18)
Diluted $ (0.15) $ (0.04) $ (0.28) $ (0.18)
Net loss:
Basic $ (0.14) $ (0.07) $ (0.30) $ (0.43)
Diluted $ (0.14) $ (0.07) $ (0.30) $ (0.43)
DATASOURCE: OptiCare Health Systems, Inc.
CONTACT: William A. Blaskiewicz, Chief Financial Officer of OptiCare
Health Systems, Inc., +1-203-596-2236